Patents by Inventor Robert A. Soslow

Robert A. Soslow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF OVARIAN CANCERS THAT ARE ASSOCIATED WITH REDUCED SMARCA4 GENE EXPRESSION OR PROTEIN FUNCTION
    Publication number: 20190309371
    Abstract: Provided are compositions and methods for the identification and treatment of ovarian cancers, such as small cell ovarian cancers, in particular small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), which ovarian cancers are characterized by reduced SMARCA4 gene expression and/or protein function and, as a consequence, are sensitive to growth and/or survival inhibition by one or more compounds that restore SMARCA4 gene expression and/or protein function.
    Type: Application
    Filed: January 1, 2019
    Publication date: October 10, 2019
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Douglas A. Levine, Michael F. Berger, Robert A. Soslow, Petar Jelinic
  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF OVARIAN CANCERS THAT ARE ASSOCIATED WITH REDUCED SMARCA4 GENE EXPRESSION OR PROTEIN FUNCTION
    Publication number: 20160326596
    Abstract: Provided are compositions and methods for the identification and treatment of ovarian cancers, such as small cell ovarian cancers, in particular small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), which ovarian cancers are characterized by reduced SMARCA4 gene expression and/or protein function and, as a consequence, are sensitive to growth and/or survival inhibition by one or more compounds that restore SMARCA4 gene expression and/or protein function.
    Type: Application
    Filed: December 31, 2014
    Publication date: November 10, 2016
    Inventors: Douglas A. Levine, Michael F. Berger, Robert A. Soslow, Petar Jelinic